name: Open repair of recurrent strangulated incisional hernia with length 3-10 cm with implantation of prosthesis


name: Open repair of recurrent strangulated spigelian hernia with length 3-10 cm with implantation of prosthesis


name: Open repair of recurrent strangulated ventral hernia with length 3-10 cm


name: Open repair of recurrent strangulated ventral hernia with length 3-10 cm with implantation of mesh


name: Open repair of recurrent strangulated ventral hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent incarcerated epigastric hernia with length 3-10 cm


name: Robotic repair of recurrent incarcerated epigastric hernia with length 3-10 cm with implantation of mesh


name: Robotic repair of recurrent incarcerated epigastric hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent incarcerated incisional hernia with length 3-10 cm


name: Robotic repair of recurrent incarcerated incisional hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent incarcerated spigelian hernia with length 3-10 cm


name: Robotic repair of recurrent incarcerated spigelian hernia with length 3-10 cm with implantation of mesh


name: Robotic repair of recurrent incarcerated spigelian hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent incarcerated umbilical hernia with length 3-10 cm


name: Robotic repair of recurrent incarcerated umbilical hernia with length 3-10 cm with implantation of mesh


name: Robotic repair of recurrent incarcerated umbilical hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent incarcerated ventral hernia with length 3-10 cm


name: Robotic repair of recurrent incarcerated ventral hernia with length 3-10 cm with implantation of mesh


name: Robotic repair of recurrent incarcerated ventral hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent strangulated epigastric hernia with length 3-10 cm


name: Robotic repair of recurrent strangulated epigastric hernia with length 3-10 cm with implantation of mesh


name: Robotic repair of recurrent strangulated epigastric hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent strangulated incisional hernia with length 3-10 cm


name: Robotic repair of recurrent strangulated incisional hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent strangulated spigelian hernia with length 3-10 cm


name: Robotic repair of recurrent strangulated spigelian hernia with length 3-10 cm with implantation of mesh


name: Robotic repair of recurrent strangulated spigelian hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent strangulated umbilical hernia with length 3-10 cm


name: Robotic repair of recurrent strangulated umbilical hernia with length 3-10 cm with implantation of mesh


name: Robotic repair of recurrent strangulated umbilical hernia with length 3-10 cm with implantation of prosthesis


name: Robotic repair of recurrent strangulated ventral hernia with length 3-10 cm


name: Robotic repair of recurrent strangulated ventral hernia with length 3-10 cm with implantation of mesh


name: Robotic repair of recurrent strangulated ventral hernia with length 3-10 cm with implantation of prosthesis


name: Repair of anterior abdominal hernia(s) (ie, epigastric, incisional, ventral, umbilical, spigelian), any approach (ie, open, laparoscopic, robotic), recurrent, including implantation of mesh or other prosthesis when performed, total length of defect(s); greater than 10 cm, reducible


name: Repair of recurrent sliding hernia of abdomen, more than 10 cm in length


name: Laparoscopic repair of recurrent reducible epigastric hernia with length more than 10 cm


name: Laparoscopic repair of recurrent reducible epigastric hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent reducible epigastric hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent reducible incisional hernia with length more than 10 cm


name: Laparoscopic repair of recurrent reducible incisional hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent reducible incisional hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent reducible spigelian hernia with length more than 10 cm


name: Laparoscopic repair of recurrent reducible spigelian hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent reducible spigelian hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent reducible umbilical hernia with length more than 10 cm


name: Laparoscopic repair of recurrent reducible umbilical hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent reducible umbilical hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent reducible ventral hernia with length more than 10 cm


name: Open repair of recurrent reducible epigastric hernia with length more than 10 cm


name: Open repair of recurrent reducible epigastric hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent reducible epigastric hernia with length more than 10 cm with implantation of prosthesis


name: Open repair of recurrent reducible incisional hernia with length more than 10 cm


name: Open repair of recurrent reducible incisional hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent reducible incisional hernia with length more than 10 cm with implantation of prosthesis


name: Open repair of recurrent reducible spigelian hernia with length more than 10 cm


name: Open repair of recurrent reducible spigelian hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent reducible spigelian hernia with length more than 10 cm with implantation of prosthesis


name: Open repair of recurrent reducible ventral hernia with length more than 10 cm


name: Open repair of recurrent reducible ventral hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent reducible ventral hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent reducible epigastric hernia with length more than 10 cm


name: Robotic repair of recurrent reducible epigastric hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent reducible epigastric hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent reducible incisional hernia with length more than 10 cm


name: Robotic repair of recurrent reducible incisional hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent reducible spigelian hernia with length more than 10 cm


name: Robotic repair of recurrent reducible spigelian hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent reducible spigelian hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent reducible umbilical hernia with length more than 10 cm


name: Robotic repair of recurrent reducible umbilical hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent reducible umbilical hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent reducible ventral hernia with length more than 10 cm


name: Robotic repair of recurrent reducible ventral hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent reducible ventral hernia with length more than 10 cm with implantation of prosthesis


name: Repair of anterior abdominal hernia(s) (ie, epigastric, incisional, ventral, umbilical, spigelian), any approach (ie, open, laparoscopic, robotic), recurrent, including implantation of mesh or other prosthesis when performed, total length of defect(s); greater than 10 cm, incarcerated or strangulated


name: Repair of recurrent entrapped hernia of abdomen, more than 10 cm in length


name: Initial laparoscopic repair of incarcerated spigelian hernia with length more than 10 cm


name: Initial laparoscopic repair of strangulated spigelian hernia with length more than 10 cm


name: Laparoscopic repair of recurrent incarcerated epigastric hernia with length more than 10 cm


name: Laparoscopic repair of recurrent incarcerated epigastric hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent incarcerated epigastric hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent incarcerated incisional hernia with length more than 10 cm


name: Laparoscopic repair of recurrent incarcerated incisional hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent incarcerated incisional hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent incarcerated umbilical hernia with length more than 10 cm


name: Laparoscopic repair of recurrent incarcerated umbilical hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent incarcerated umbilical hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent incarcerated ventral hernia with length more than 10 cm


name: Laparoscopic repair of recurrent strangulated epigastric hernia with length more than 10 cm


name: Laparoscopic repair of recurrent strangulated epigastric hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent strangulated epigastric hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent strangulated incisional hernia with length more than 10 cm


name: Laparoscopic repair of recurrent strangulated incisional hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent strangulated incisional hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent strangulated umbilical hernia with length more than 10 cm


name: Laparoscopic repair of recurrent strangulated umbilical hernia with length more than 10 cm with implantation of mesh


name: Laparoscopic repair of recurrent strangulated umbilical hernia with length more than 10 cm with implantation of prosthesis


name: Laparoscopic repair of recurrent strangulated ventral hernia with length more than 10 cm


name: Open repair of recurrent incarcerated epigastric hernia with length more than 10 cm


name: Open repair of recurrent incarcerated epigastric hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent incarcerated epigastric hernia with length more than 10 cm with implantation of prosthesis


name: Open repair of recurrent incarcerated incisional hernia with length more than 10 cm


name: Open repair of recurrent incarcerated incisional hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent incarcerated incisional hernia with length more than 10 cm with implantation of prosthesis


name: Open repair of recurrent incarcerated ventral hernia with length more than 10 cm


name: Open repair of recurrent incarcerated ventral hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent incarcerated ventral hernia with length more than 10 cm with implantation of prosthesis


name: Open repair of recurrent strangulated epigastric hernia with length more than 10 cm


name: Open repair of recurrent strangulated epigastric hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent strangulated epigastric hernia with length more than 10 cm with implantation of prosthesis


name: Open repair of recurrent strangulated incisional hernia with length more than 10 cm


name: Open repair of recurrent strangulated incisional hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent strangulated incisional hernia with length more than 10 cm with implantation of prosthesis


name: Open repair of recurrent strangulated ventral hernia with length more than 10 cm


name: Open repair of recurrent strangulated ventral hernia with length more than 10 cm with implantation of mesh


name: Open repair of recurrent strangulated ventral hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent incarcerated epigastric hernia with length more than 10 cm


name: Robotic repair of recurrent incarcerated epigastric hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent incarcerated epigastric hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent incarcerated incisional hernia with length more than 10 cm


name: Robotic repair of recurrent incarcerated incisional hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent incarcerated incisional hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent incarcerated umbilical hernia with length more than 10 cm


name: Robotic repair of recurrent incarcerated umbilical hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent incarcerated umbilical hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent incarcerated ventral hernia with length more than 10 cm


name: Robotic repair of recurrent incarcerated ventral hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent incarcerated ventral hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent strangulated epigastric hernia with length more than 10 cm


name: Robotic repair of recurrent strangulated epigastric hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent strangulated epigastric hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent strangulated incisional hernia with length more than 10 cm


name: Robotic repair of recurrent strangulated incisional hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent strangulated incisional hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent strangulated umbilical hernia with length more than 10 cm


name: Robotic repair of recurrent strangulated umbilical hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent strangulated umbilical hernia with length more than 10 cm with implantation of prosthesis


name: Robotic repair of recurrent strangulated ventral hernia with length more than 10 cm


name: Robotic repair of recurrent strangulated ventral hernia with length more than 10 cm with implantation of mesh


name: Robotic repair of recurrent strangulated ventral hernia with length more than 10 cm with implantation of prosthesis


name: Repair of parastomal hernia, any approach (ie, open, laparoscopic, robotic), initial or recurrent, including implantation of mesh or other prosthesis, when performed


name: Repair of parastomal hernia, any approach (ie, open, laparoscopic, robotic), initial or recurrent, including implantation of mesh or other prosthesis, when performed; reducible


name: Initial laparoscopic repair of reducible parastomal hernia


name: Initial laparoscopic repair of reducible parastomal hernia using mesh


name: Initial laparoscopic repair of reducible parastomal hernia using prosthesis


name: Initial open repair of reducible parastomal hernia


name: Initial open repair of reducible parastomal hernia using mesh


name: Initial open repair of reducible parastomal hernia using prosthesis


name: Initial robotic repair of reducible parastomal hernia


name: Initial robotic repair of reducible parastomal hernia using mesh


name: Initial robotic repair of reducible parastomal hernia using prosthesis


name: Laparoscopic repair of recurrent reducible parastomal hernia


name: Laparoscopic repair of recurrent reducible parastomal hernia using mesh


name: Laparoscopic repair of recurrent reducible parastomal hernia using prosthesis


name: Open repair of recurrent reducible parastomal hernia


name: Open repair of recurrent reducible parastomal hernia using mesh


name: Open repair of recurrent reducible parastomal hernia using prosthesis


name: Robotic repair of recurrent reducible parastomal hernia


name: Robotic repair of recurrent reducible parastomal hernia using mesh


name: Robotic repair of recurrent reducible parastomal hernia using prosthesis


name: Repair of parastomal hernia, any approach (ie, open, laparoscopic, robotic), initial or recurrent, including implantation of mesh or other prosthesis, when performed; incarcerated or strangulated


name: Repair of entrapped hernia next to stoma


name: Initial laparoscopic repair of incarcerated parastomal hernia


name: Initial laparoscopic repair of incarcerated parastomal hernia using mesh


name: Initial laparoscopic repair of incarcerated parastomal hernia using prosthesis


name: Initial laparoscopic repair of strangulated parastomal hernia


name: Initial laparoscopic repair of strangulated parastomal hernia using mesh


name: Initial laparoscopic repair of strangulated parastomal hernia using prosthesis


name: Initial open repair of incarcerated parastomal hernia


name: Initial open repair of incarcerated parastomal hernia using mesh


name: Initial open repair of incarcerated parastomal hernia using prosthesis


name: Initial open repair of strangulated parastomal hernia


name: Initial open repair of strangulatedd parastomal hernia using mesh


name: Initial robotic repair of incarcerated parastomal hernia


name: Initial robotic repair of incarcerated parastomal hernia using prosthesis


name: Initial robotic repair of incarcerated reducible parastomal hernia using mesh


name: Initial robotic repair of strangulated parastomal hernia


name: Initial robotic repair of strangulated parastomal hernia using prosthesis


name: Initial robotic repair of strangulated reducible parastomal hernia using mesh


name: Laparoscopic repair of recurrent incarcerated parastomal hernia


name: Laparoscopic repair of recurrent incarcerated parastomal hernia using mesh


name: Laparoscopic repair of recurrent incarcerated parastomal hernia using prosthesis


name: Laparoscopic repair of recurrent strangulated parastomal hernia


name: Laparoscopic repair of recurrent strangulated parastomal hernia using prosthesis


name: Open repair of recurrent incarcerated parastomal hernia


name: Open repair of recurrent incarcerated parastomal hernia using mesh


name: Open repair of recurrent incarcerated parastomal hernia using prosthesis


name: Open repair of recurrent strangulated parastomal hernia


name: Open repair of recurrent strangulated parastomal hernia using mesh


name: Open repair of recurrent strangulated parastomal hernia using prosthesis


name: Robotic repair of recurrent incarcerated parastomal hernia


name: Robotic repair of recurrent incarcerated parastomal hernia using mesh


name: Robotic repair of recurrent incarcerated parastomal hernia using prosthesis


name: Robotic repair of recurrent strangulated parastomal hernia


name: Robotic repair of recurrent strangulated parastomal hernia using mesh


name: Robotic repair of recurrent strangulated parastomal hernia using prosthesis


name: Removal of total or near total non-infected mesh or other prosthesis at the time of initial or recurrent anterior abdominal hernia repair or parastomal hernia repair, any approach (ie, open, laparoscopic, robotic) (List separately in addition to code for primary procedure)


name: Removal of mesh at same time as hernia repair


name: Laparoscopic removal of near-total noninfected mesh at time of anterior abdominal hernia repair


name: Laparoscopic removal of near-total noninfected mesh at time of parastomal hernia repair


name: Laparoscopic removal of total noninfected mesh at time of anterior abdominal hernia repair


name: Laparoscopic removal of total noninfected mesh at time of parastomal hernia repair


name: Open removal of near-total noninfected mesh at time of anterior abdominal hernia repair


name: Open removal of near-total noninfected mesh at time of parastomal hernia repair


name: Open removal of total noninfected mesh at time of anterior abdominal hernia repair


name: Open removal of total noninfected mesh at time of parastomal hernia repair


name: Robotic removal of near-total noninfected mesh at time of anterior abdominal hernia repair


name: Robotic removal of near-total noninfected mesh at time of parastomal hernia repair


name: Robotic removal of total noninfected mesh at time of anterior abdominal hernia repair


name: Robotic removal of total noninfected mesh at time of parastomal hernia repair


name: Percutaneous nephrolithotomy or pyelolithotomy, lithotripsy, stone extraction, antegrade ureteroscopy, antegrade stent placement and nephrostomy tube placement, when performed, including imaging guidance


name: Simple surgical treatment of kidney stone with imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade stent placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade ureteroscopy, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) up to 2 cm in single location of kidney or renal pelvis with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of unbranched stone(s) with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of unbranched stone(s) with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of unbranched stone(s) with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of unbranched stone(s) with antegrade uretroscopy, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with extraction of unbranched stone(s) with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy and extraction of unbranched stone(s), using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy and stone extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade stent placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy of stone(s) up to 2 cm in single location of kidney or renal pelvis with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy of unbranched stone(s) with antegrade stent placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy of unbranched stone(s) with antegrade uretroscopy, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy of unbranched stone(s) with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade stent placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of unbranched stone(s) with antegrade stent placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of unbranched stone(s) with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of stone(s) with lithotripsy, stone extration of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of unbranched stone(s) with antegrade stent placement, using imaging guidance


name: Simple percutaneous nephrolithotomy of unbranched stone(s) with antegrade ureteroscopy, using imaging guidance


name: Simple percutaneous nephrolithotomy of unbranched stone(s) with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous nephrolithotomy with extraction of unbranched stone(s), using imaging guidance


name: Simple percutaneous nephrolithotomy with lithotripsy of stone(s) up to 2 cm in single location of kidney or renal pelvis, using imaging guidance


name: Simple percutaneous nephrolithotomy with lithotripsy of unbranched stone(s), using imaging guidance


name: Simple percutaneous nephrolithotomy with stone extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade stent placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade ureteroscopy, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) up to 2 cm in single location of kidney or renal pelvis with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of unbranched stone(s) with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of unbranched stone(s) with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of unbranched stone(s) with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of unbranched stone(s) with antegrade uretroscopy, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with extraction of unbranched stone(s) with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy and extraction of unbranched stone(s), using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy and stone extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade stent placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy of stone(s) up to 2 cm in single location of kidney or renal pelvis with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy of unbranched stone(s) with antegrade stent placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy of unbranched stone(s) with antegrade uretroscopy, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy of unbranched stone(s) with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade stent placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of unbranched stone(s) with antegrade stent placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of unbranched stone(s) with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of stone(s) with lithotripsy, stone extration of stone(s) up to 2 cm in single location of kidney or renal pelvis with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of unbranched stone(s) with antegrade stent placement, using imaging guidance


name: Simple percutaneous pyelolithotomy of unbranched stone(s) with antegrade ureteroscopy, using imaging guidance


name: Simple percutaneous pyelolithotomy of unbranched stone(s) with nephrostomy tube placement, using imaging guidance


name: Simple percutaneous pyelolithotomy with extraction of unbranched stone(s), using imaging guidance


name: Simple percutaneous pyelolithotomy with lithotripsy of stone(s) up to 2 cm in single location of kidney or renal pelvis, using imaging guidance


name: Simple percutaneous pyelolithotomy with lithotripsy of unbranched stone(s), using imaging guidance


name: Simple percutaneous pyelolithotomy with stone extraction of stone(s) up to 2 cm in single location of kidney or renal pelvis, using imaging guidance


name: Complex surgical treatment of kidney stone with imaging guidance


name: Complex percutaneous nephrolithotomy of branching stone(s) with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of branching stone(s) with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of branching stone(s) with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) over 2 cm with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) over 2 cm with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) over 2 cm with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of branching stone(s) with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of branching stone(s) with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of branching stone(s) with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of branching stone(s) with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of branching stone(s) with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stone(s) over 2 cm iwith antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stone(s) over 2 cm with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stone(s) over 2 cm with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stone(s) over 2 cm with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stone(s) over 2 cm with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stones in multiple locations with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stones in multiple locations with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stones in multiple locations with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stones in multiple locations with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of stones in multiple locations with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of ureter stones with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of ureter stones with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of ureter stones with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of ureter stones with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction of ureter stones with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction with complicated anatomy with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction with complicated anatomy with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction with complicated anatomy with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with extraction with complicated anatomy with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy and extraction of branching stone(s), using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy and extraction of stones in multiple locations, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy and extraction of ureter stones, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy and extraction with complicated anatomy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy and stone extraction of stone(s) over 2 cm, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of branching stone(s) with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of branching stone(s) with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of branching stone(s) with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of stone(s) over 2 cm with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of stone(s) over 2 cm with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of stone(s) over 2 cm with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of stones in multiple locations with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of stones in multiple locations with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of stones in multiple locations with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of ureter stones with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of ureter stones with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy of ureter stones with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy with complicated anatomy with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy with complicated anatomy with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy with complicated anatomy with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of branching stone(s) with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of branching stone(s) with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of stone(s) over 2 cm with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of stones in multiple locations with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of stones in multiple locations with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of ureter stones with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction of ureter stones with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction with complicated anatomy with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, extraction with complicated anatomy with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stone(s) with lithotripsy, stone extration of stone(s) over 2 cm with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stones in multiple locations with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of stones in multiple locations with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of stones in multiple locations with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of ureter stones with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy of ureter stones with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy of ureter stones with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy with complicated anatomy with antegrade stent placement, using imaging guidance


name: Complex percutaneous nephrolithotomy with complicated anatomy with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous nephrolithotomy with complicated anatomy with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous nephrolithotomy with extraction of branching stone(s), using imaging guidance


name: Complex percutaneous nephrolithotomy with extraction of stones in multiple locations, using imaging guidance


name: Complex percutaneous nephrolithotomy with extraction of ureter stones, using imaging guidance


name: Complex percutaneous nephrolithotomy with extraction with complicated anatomy, using imaging guidance


name: Complex percutaneous nephrolithotomy with lithotripsy of branching stone(s) using imaging guidance


name: Complex percutaneous nephrolithotomy with lithotripsy of stone(s) over 2 cm, using imaging guidance


name: Complex percutaneous nephrolithotomy with lithotripsy of stones in multiple locations using imaging guidance


name: Complex percutaneous nephrolithotomy with lithotripsy of ureter stones using imaging guidance


name: Complex percutaneous nephrolithotomy with lithotripsy with complicated anatomy using imaging guidance


name: Complex percutaneous nephrolithotomy with stone extraction of stone(s) over 2 cm i, using imaging guidance


name: Complex percutaneous pyelolithotomy of branching stone(s) with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of branching stone(s) with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of branching stone(s) with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) over 2 cm iwith antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) over 2 cm with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) over 2 cm with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of branching stone(s) with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of branching stone(s) with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of branching stone(s) with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of branching stone(s) with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of branching stone(s) with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stone(s) over 2 cm i with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stone(s) over 2 cm i with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stone(s) over 2 cm iwith antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stone(s) over 2 cm with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stone(s) over 2 cm with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stones in multiple locations with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stones in multiple locations with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stones in multiple locations with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stones in multiple locations with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of stones in multiple locations with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of ureter stones with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of ureter stones with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of ureter stones with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of ureter stones with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction of ureter stones with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction with complicated anatomy with antegrade stent placement and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction with complicated anatomy with antegrade uretroscopy and antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction with complicated anatomy with antegrade uretroscopy and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with extraction with complicated anatomy with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy and extraction of branching stone(s), using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy and extraction of stones in multiple locations, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy and extraction of ureter stones, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy and extraction with complicated anatomy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy and stone extraction of stone(s) over 2 cm, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of branching stone(s) with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of branching stone(s) with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of branching stone(s) with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of stone(s) over 2 cm uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of stone(s) over 2 cm with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of stone(s) over 2 cm with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of stones in multiple locations with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of stones in multiple locations with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of stones in multiple locations with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of ureter stones with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of ureter stones with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy of ureter stones with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy with complicated anatomy with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy with complicated anatomy with antegrade uretroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy with complicated anatomy with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of branching stone(s) with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of branching stone(s) with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of stone(s) over 2 cm with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of stones in multiple locations with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of stones in multiple locations with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of ureter stones with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction of ureter stones with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction with complicated anatomy with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, extraction with complicated anatomy with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stone(s) with lithotripsy, stone extration of stone(s) over 2 cm with antegrade uretroscopy, antegrade stent placement, and nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stones in multiple locations with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of stones in multiple locations with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of stones in multiple locations with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of ureter stones with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy of ureter stones with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy of ureter stones with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy with complicated anatomy with antegrade stent placement, using imaging guidance


name: Complex percutaneous pyelolithotomy with complicated anatomy with antegrade ureteroscopy, using imaging guidance


name: Complex percutaneous pyelolithotomy with complicated anatomy with nephrostomy tube placement, using imaging guidance


name: Complex percutaneous pyelolithotomy with extraction of branching stone(s), using imaging guidance


name: Complex percutaneous pyelolithotomy with extraction of stones in multiple locations, using imaging guidance


name: Complex percutaneous pyelolithotomy with extraction of ureter stones, using imaging guidance


name: Complex percutaneous pyelolithotomy with extraction with complicated anatomy, using imaging guidance


name: Complex percutaneous pyelolithotomy with lithotripsy of branching stone(s), using imaging guidance


name: Complex percutaneous pyelolithotomy with lithotripsy of stone(s) over 2 cm, using imaging guidance


name: Complex percutaneous pyelolithotomy with lithotripsy of stones in multiple locations, using imaging guidance


name: Complex percutaneous pyelolithotomy with lithotripsy of ureter stones, using imaging guidance


name: Complex percutaneous pyelolithotomy with lithotripsy with complicated anatomy, using imaging guidance


name: Complex percutaneous pyelolithotomy with stone extraction of stone(s) over 2 cm, using imaging guidance


name: Laparoscopy, surgical prostatectomy, simple subtotal (including control of postoperative bleeding, vasectomy, meatotomy, urethral calibration and/or dilation, and internal urethrotomy), includes robotic assistance, when performed


name: Simple surgical subtotal removal of prostate using laparoscope


name: Laparoscopic simple subtotal surgical prostatectomy


name: Robot-assisted laparoscopic simple subtotal surgical prostatectomy urethrotomy


name: Injection of anesthetic agent and/or steroid into arm nerve bundle (brachial plexus)


name: Injection of anesthetic agent and steroid into brachial plexus using imaging guidance


name: Injection of anesthetic agent into brachial plexus using imaging guidance


name: Injection of steroid into brachial plexus using imaging guidance


name: Continuous infusion of anesthetic agent and/or steroid into arm nerve bundle through catheter


name: Continuous infusion of anesthetic agent and steroid into brachial plexus with insertion of catheter using imaging guidance


name: Continuous infusion of anesthetic agent into brachial plexus with insertion of catheter using imaging guidance


name: Continuous infusion of steroid into brachial plexus with insertion of catheter using imaging guidance


name: Injection of anesthetic agent and steroid into axillary nerve using imaging guidance


name: Injection of anesthetic agent into axillary nerve using imaging guidance


name: Injection of steroid into axillary nerve using imaging guidance


name: Injection of anesthetic agent and steroid into sciatic nerve using imaging guidance


name: Injection of anesthetic agent into sciatic nerve using imaging guidance


name: Injection of steroid into sciatic nerve using imaging guidance


name: Continuous infusion of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) through catheter


name: Continuous infusion of anesthetic agent into sciatic nerve with insertion of catheter using imaging guidance


name: Continuous infusion of steroid into sciatic nerve with insertion of catheter using imaging guidance


name: Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve)


name: Injection of anesthetic agent and steroid into femoral nerve using imaging guidance


name: Injection of anesthetic agent into femoral nerve using imaging guidance


name: Injection of steroid into femoral nerve using imaging guidance


name: Continuous infusion of anesthetic agent and/or steroid into thigh nerve (femoral nerve) through catheter


name: Continuous infusion of anesthetic agent and steroid into femoral nerve with insertion of catheter using imaging guidance


name: Continuous infusion of anesthetic agent into femoral nerve with insertion of catheter using imaging guidance


name: Continuous infusion of steroid into femoral nerve with insertion of catheter using imaging guidance


name: Transluminal dilation of aqueous outflow canal (eg, canaloplasty)


name: Dilation of fluid outflow drainage within eye


name: Dilation of fluid outflow drainage within eye with insertion of device to maintain open channel


name: Implantation of cochlear stimulating system into mastoid bone of skull with magnetic attachment to external speech processor


name: Implantation of osseointegrated implant in skull with removal of less than 100 sq mm surface area of bone deep to outer cranial cortex, with magnetic transcutaneous attachment to external speech processor


name: Implantation of osseointegrated implant in skull within mastoid with magnetic transcutaneous attachment to external speech processor


name: Implantation, osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor, outside of the mastoid and resulting in removal of greater than or equal to 100 sq mm surface area of bone deep to the outer cranial cortex


name: Implantation of cochlear stimulating system outside mastoid bone of skull with magnetic attachment to external speech processor


name: Replacement (including removal of existing device), osseointegrated implant, skull


name: Replacement of cochlear stimulating system into mastoid bone of skull with magnetic attachment to external speech processor


name: Removal and replacement of osseointegrated implant in skull involving bony defect less than 100 sq mm surface area of bone deep to outer cranial cortex with magnetic transcutaneous attachment to external speech processor


name: Removal and replacement of osseointegrated implant in skull within mastoid with magnetic transcutaneous attachment to external speech processor


name: Replacement (including removal of existing device), osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor, outside the mastoid and involving a bony defect greater than or equal to 100 sq mm surface area of bone deep to the outer cranial cortex


name: Replacement of cochlear stimulating system outside mastoid bone of skull with magnetic attachment to external speech processor


name: Removal of entire cochlear stimulating system from skull with attachment through skin to external speech processor


name: Removal of entire cochlear stimulating system from mastoid bone of skull with magnetic attachment to external speech processor


name: Removal of entire osseointegrated implant in skull involving bony defect in less than 100 sq mm surface area of bone deep to outer cranial cortex with magnetic transcutaneous attachment to external speech processor


name: Removal of entire osseointegrated implant in skull within mastoid with magnetic transcutaneous attachment to external speech processor


name: Removal, entire osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor, outside the mastoid and involving a bony defect greater than or equal to 100 sq mm surface area of bone deep to the outer cranial cortex


name: Limited ultrasound scan of joint or other extremity structure except blood vessels


name: Limited real time ultrasound of muscle of extremity, with image documentation


name: Limited real time ultrasound of muscles of extremity, with image documentation


name: Limited real time ultrasound of nerve of extremity, with image documentation


name: Limited real time ultrasound of nerves of extremity, with image documentation


name: Ultrasound, nerve(s) and accompanying structures throughout their entire anatomic course in one extremity, comprehensive, including real-time cine imaging with image documentation, per extremity


name: Comprehensive ultrasound scan of entire length of nerves in extremity


name: Comprehensive ultrasound of nerves and accompanying structures throughout their entire anatomic course in one extremity with real-time cine imaging with image documentation,


name: Nuclear medicine study, SPECT imaging, 1 area or single acquisition, single day imaging


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agents, single acquisition, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agents, single acquisition, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation, single acquisition, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation, single acquisition, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor, single acquisition, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor, single acquisition, with vascular flow and blood pool imaging, single day


name: Nuclear medicine study, SPECT imaging with concurrent CT scan, 1 area or single acquisition, single day imaging


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent, single acquisition, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation, single acquisition, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in pelvis, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor, single acquisition, with concurrently acquired computed tomography (CT) transmission, single day


name: Nuclear medicine study, SPECT imaging, at least 2 areas or separate acquisitions, single day imaging, or single area or acquisition over multiple days


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in chest and abdomen, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in chest and abdomen, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent with vascular flow and blood pool imaging, single acquisition over multiple days


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent, single acquisition over multiple days


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agents in chest and abdomen, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agents in chest and abdomen, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agents with vascular flow and blood pool imaging, single acquisition over multiple days


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agents, single acquisition over multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in chest and abdomen, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in chest and abdomen, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation, single acquisition over multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation, with vascular flow and blood pool imaging, single acquisition over multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in chest and abdomen, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in chest and abdomen, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor with vascular flow and blood pool imaging, single acquisition over multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor, single acquisition over multiple days


name: Nuclear medicine study, SPECT imaging with concurrent CT scan, at least 2 areas or separate acquisitions, single day imaging, or single area or acquisition over multiple days


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in chest and abdomen with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in chest and abdomen, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agents in chest and abdomen with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agents in chest and abdomen, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in chest and abdomen with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in chest and abdomen, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Drug metabolism (eg, pharmacogenomics) genomic sequence analysis panel, must include testing of at least 6 genes, including CYP2C19, CYP2D6, and CYP2D6 duplication/deletion analysis


name: Inherited bone marrow failure syndromes (IBMFS) (eg, Fanconi anemia, dyskeratosis congenita, Diamond-Blackfan anemia, Shwachman-Diamond syndrome, GATA2 deficiency syndrome, congenital amegakaryocytic thrombocytopenia) sequence analysis panel, must include sequencing of at least 30 genes, including BRCA2, BRIP1, DKC1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, GATA1, GATA2, MPL, NHP2, NOP10, PALB2, RAD51C, RPL11, RPL35A, RPL5, RPS10, RPS19, RPS24, RPS26, RPS7, SBDS, TERT, and TINF2


name: Gene sequence analysis panel at least 30 genes associated with inherited bone marrow failure syndromes


name: Genetic sequence analysis panel for inherited bone marrow failure syndromes (IBMFS) with sequencing of at least 30 genes


name: Solid organ neoplasm, genomic sequence analysis panel, 5-50 genes, interrogation for sequence variants and copy number variants or rearrangements, if performed; RNA analysis


name: Hematolymphoid neoplasm or disorder, genomic sequence analysis panel, 5-50 genes, interrogation for sequence variants, and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; RNA analysis


name: Solid organ or hematolymphoid neoplasm or disorder, 51 or greater genes, genomic sequence analysis panel, interrogation for sequence variants and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; RNA analysis


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; hepatitis B surface antigen (HBsAg), quantitative


name: Infectious agent detection by nucleic acid (DNA or RNA); Anaplasma phagocytophilum, amplified probe technique


name: Infectious agent detection by nucleic acid (DNA or RNA); Babesia microti, amplified probe technique


name: Detection of Babesia microtim by amplified nucleic acid probe technique


name: Detection of Babesia microti nucleic acid by amplified DNA probe technique


name: Detection of Babesia microti nucleic acid by amplified RNA probe technique


name: Infectious agent detection by nucleic acid (DNA or RNA); Borrelia miyamotoi, amplified probe technique


name: Infectious agent detection by nucleic acid (DNA or RNA); Ehrlichia chaffeensis, amplified probe technique


name: Detection of Ehrlichia chaffeensis nucleic acid by amplified RNA probe technique


name: Infectious agent detection by nucleic acid (DNA or RNA); Orthopoxvirus (eg, monkeypox virus, cowpox virus, vaccinia virus), amplified probe technique, each


name: Detection of cowpox virus nucleic acid by amplified DNA probe technique


name: Detection of cowpox virus nucleic acid by amplified RNA probe technique


name: Detection of monkeypox virus nucleic acid by amplified DNA probe technique


name: Detection of monkeypox virus nucleic acid by amplified RNA probe technique


name: Detection of Orthopox virus nucleic acid by amplified RNA probe technique


name: Detection of vaccinia virus nucleic acid by amplified DNA probe technique


name: Detection of vaccinia virus nucleic acid by amplified RNA probe technique


name: Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identification in targeted region(s)


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identification in targeted region by DNA genotype analysis


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identification in targeted region by RNA genotype analysis


name: Evaluation of gastric emptying by measurement of radiolabeled carbon dioxide in breath specimens


name: Genomic sequence analysis of 42 genes for detection of abnormalities associated with inherited thrombocytopenia (low platelet count)


name: Genomic sequence analysis of 42 genes associated with inherited thrombocytopenia in amniotic fluid specimen


name: Genomic sequence analysis of 42 genes associated with inherited thrombocytopenia in blood specimen


name: Genomic sequence analysis of 42 genes associated with inherited thrombocytopenia in buccal swab specimen


name: Oncology, response to radiation, cell-free DNA, quantitative branched chain DNA amplification, plasma, reported as a radiation toxicity score


name: Evaluation of response to radiation in cell-free DNA by quantitative branched chain DNA amplification, reported as radiation toxicity score


name: CEP72 (centrosomal protein, 72-KDa), NUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variants


name: Oncology (thyroid), DNA and mRNA, next-generation sequencing analysis of 112 genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithmic prediction of cancer recurrence, reported as a categorical risk result (low, intermediate, high)


name: Next-generation DNA and RNA sequencing of 112 genes in tumor specimen, with algorithmic prediction of cancer recurrence, reported as a categorical risk result (low, intermediate, high)


name: DNA and mRNA next-generation sequencing analysis of 112 genes in fine needle aspirate of thyroid tissue, algorithmic prediction of thyroid cancer recurrence, reported as categorical risk result (low, intermediate, high)


name: DNA and mRNA next-generation sequencing analysis of 112 genes in formalin-fixed paraffin-embedded (FFPE) thyroid tissue with algorithmic prediction of thyroid cancer recurrence, reported as categorical risk result (low, intermediate, high)


name: Oncology (lung), mRNA, quantitative PCR analysis of 11 genes (BAG1, BRCA1, CDC6, CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3, SH3BGR, WNT3A) and 3 reference genes (ESD, TBP, YAP1), formalin-fixed paraffin-embedded (FFPE) tumor tissue, algorithmic interpretation reported as a recurrence risk score


name: PCR measurement of 11 genes (BAG1, BRCA1, CDC6, CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3, SH3BGR, WNT3A) and 3 reference genes (ESD, TBP, YAP1), in tumor tissue, with algorithmic interpretation reported as a recurrence risk score


name: Neurology (Alzheimer disease), mRNA, gene expression profiling by RNA sequencing of 24 genes, whole blood, algorithm reported as predictive risk score


name: Pain management, mRNA, gene expression profiling by RNA sequencing of 36 genes, whole blood, algorithm reported as predictive risk score


name: Psychiatry (mood disorders), mRNA, gene expression profiling by RNA sequencing of 144 genes, whole blood, algorithm reported as predictive risk score


name: Psychiatry (stress disorders), mRNA, gene expression profiling by RNA sequencing of 72 genes, whole blood, algorithm reported as predictive risk score


name: Psychiatry (suicidal ideation), mRNA, gene expression profiling by RNA sequencing of 54 genes, whole blood, algorithm reported as predictive risk score


name: Longevity and mortality risk, mRNA, gene expression profiling by RNA sequencing of 18 genes, whole blood, algorithm reported as predictive risk score


name: mRNA gene expression profiling of 18 genes in whole blood for detection of abnormalities associated with life expectancy, algorithm reported as predictive risk score


name: Oncology (breast ductal carcinoma in situ), protein expression profiling by immunohistochemistry of 7 proteins (COX2, FOXA1, HER2, Ki-67, p16, PR, SIAH2), with 4 clinicopathologic factors (size, age, margin status, palpability), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a recurrence risk score


name: Protein expression profiling by immunohistochemistry of 7 proteins (COX2, FOXA1, HER2, Ki-67, p16, PR, SIAH2), with 4 clinicopathologic factors (size, age, margin status, palpability), in breast ductal carcinoma in situ tumor tissue, algorithm reported as recurrence risk score


name: Oncology (oral and/or oropharyngeal cancer), gene expression profiling by RNA sequencing of at least 20 molecular features (eg, human and/or microbial mRNA), saliva, algorithm reported as positive or negative for signature associated with malignancy


name: mRNA gene expression profiling of at least 20 molecular features in saliva, algorithm reported as positive or negative for signature associated with mouth or mouth and pharynx cancer


name: Oncology (pan tumor), whole genome sequencing of paired malignant and normal DNA specimens, fresh or formalin-fixed paraffin-embedded (FFPE) tissue, blood or bone marrow, comparative sequence analyses and variant identification


name: Whole genome sequencing of paired tumor and normal DNA specimens, in tissue, blood or bone marrow, with comparative sequence analyses and variant identification


name: Whole genome sequencing of paired malignant and normal DNA specimens in blood specimen with comparative sequence analyses and variant identification


name: Whole genome sequencing of paired malignant and normal DNA specimens in bone marrow specimen with comparative sequence analyses and variant identification


name: Whole genome sequencing of paired malignant and normal DNA specimens in formalin-fixed paraffin-embedded (FFPE) tissue specimen with comparative sequence analyses and variant identification


name: Whole genome sequencing of paired malignant and normal DNA specimens in fresh tissue specimen with comparative sequence analyses and variant identification


name: Oncology (pan tumor), whole transcriptome sequencing of paired malignant and normal RNA specimens, fresh or formalin-fixed paraffin-embedded (FFPE) tissue, blood or bone marrow, comparative sequence analyses and expression level and chimeric transcript identification


name: Whole transcriptome sequencing of paired tumor and normal DNA specimens, in tissue, blood or bone marrow, with comparative sequence analyses and expression level and chimeric transcript identification


name: Whole transcriptome sequencing of paired malignant and normal RNA specimens in blood specimen with comparative sequence analyses and expression level and chimeric transcript identification


name: Whole transcriptome sequencing of paired malignant and normal RNA specimens in bone marrow specimen with comparative sequence analyses and expression level and chimeric transcript identification


name: Whole transcriptome sequencing of paired malignant and normal RNA specimens in formalin-fixed paraffin-embedded (FFPE) specimen with comparative sequence analyses and expression level and chimeric transcript identification


name: Whole transcriptome sequencing of paired malignant and normal RNA specimens in fresh tissue specimen with comparative sequence analyses and expression level and chimeric transcript identification


name: Oncology (pan tumor), whole genome optical genome mapping of paired malignant and normal DNA specimens, fresh frozen tissue, blood, or bone marrow, comparative structural variant identification


name: Whole transcriptome sequencing of paired tumor and normal DNA specimens, in tissue, blood or bone marrow, with comparative structural variant identification


name: Whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens in blood specimen with comparative structural variant identification


name: Whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens in bone marrow specimen with comparative structural variant identification


name: Whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens in fresh tissue specimen with comparative structural variant identification


name: Oncology (pan tumor), whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens, fresh tissue, blood, or bone marrow, comparative sequence analyses and variant identification


name: Whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens in blood specimen with comparative sequence analyses and variant identification


name: Whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens in bone marrow specimen with comparative sequence analyses and variant identification


name: Whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens in fresh tissue specimen with comparative sequence analyses and variant identification


name: Infectious agent detection by nucleic acid (DNA or RNA), Bartonella henselae and Bartonella quintana, droplet digital PCR (ddPCR);


name: Detection of Bartonella henselae and Bartonella quintana DNA by droplet digital polymerase chain reaction (ddPCR)


name: Infectious agent detection by nucleic acid (DNA or RNA), Bartonella henselae and Bartonella quintana, droplet digital PCR (ddPCR); following liquid enrichment


name: Detection of Bartonella henselae and Bartonella quintana DNA by droplet digital polymerase chain reaction (ddPCR) following liquid enrichment


name: Hematology, red blood cell (RBC) adhesion to endothelial/subendothelial adhesion molecules, functional assessment, whole blood, with algorithmic analysis and result reported as an RBC adhesion index


name: Hematology, red blood cell (RBC) adhesion to endothelial/subendothelial adhesion molecules, functional assessment, whole blood, with algorithmic analysis and result reported as an RBC adhesion index; hypoxic


name: Functional assessment of red blood cell (RBC) adhesion to endothelial adhesion molecules in hypoxic whole blood specimen, with algorithmic analysis and result reported as RBC adhesion index


name: Functional assessment of red blood cell (RBC) adhesion to subendothelial adhesion molecules in hypoxic whole blood specimen, with algorithmic analysis and result reported as RBC adhesion index


name: Hematology, red blood cell (RBC) adhesion to endothelial/subendothelial adhesion molecules, functional assessment, whole blood, with algorithmic analysis and result reported as an RBC adhesion index; normoxic


name: Functional assessment of red blood cell (RBC) adhesion to endothelial adhesion molecules in normoxic whole blood specimen, with algorithmic analysis and result reported as RBC adhesion index


name: Functional assessment of red blood cell (RBC) adhesion to subendothelial adhesion molecules in normoxic whole blood specimen, with algorithmic analysis and result reported as RBC adhesion index


name: Hematology, red blood cell (RBC) functionality and deformity as a function of shear stress, whole blood, reported as a maximum elongation index


name: Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient-specific panel for future comparisons to evaluate for MRD


name: Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis of a patient-specific panel, cell-free DNA, subsequent assessment with comparison to previously analyzed patient specimens to evaluate for MRD


name: Cardiology (coronary artery disease [CAD]), analysis of 3 proteins (high sensitivity [hs] troponin, adiponectin, and kidney injury molecule-1 [KIM-1]) with 3 clinical parameters (age, sex, history of cardiac intervention), plasma, algorithm reported as a risk score for obstructive CAD


name: Cardiology (cardiovascular disease), analysis of 4 proteins (NT-proBNP, osteopontin, tissue inhibitor of metalloproteinase-1 [TIMP-1], and kidney injury molecule-1 [KIM-1]), plasma, algorithm reported as a risk score for major adverse cardiac event


name: Pediatrics (vasculitis, Kawasaki disease [KD]), analysis of 3 biomarkers (NT-proBNP, C-reactive protein, and T-uptake), plasma, algorithm reported as a risk score for KD


name: Analysis of 3 biomarkers for Kawasaki disease (NTproBNP, C-reactive protein, and T-uptake) in plasma specimen, algorithm reported as risk score for pediatric Kawasaki disease (KD)


name: Infectious disease (bacterial), quantitative antimicrobial susceptibility reported as phenotypic minimum inhibitory concentration (MIC)-based antimicrobial susceptibility for each organism identified


name: Autoimmune diseases (eg, systemic lupus erythematosus [SLE]), analysis of 8 IgG autoantibodies and 2 cell-bound complement activation products using enzyme-linked immunosorbent immunoassay (ELISA), flow cytometry and indirect immunofluorescence, serum, or plasma and whole blood, individual components reported along with an algorithmic SLE-likelihood assessment


name: Analysis of 8 IgG autoantibodies and 2 cell-bound complement activation products associated with systemic lupus erythematosus by enzyme-linked immunosorbent immunoassay (ELISA), flow cytometry and indirect immunofluorescence in plasma and whole blood specimens, individual components reported along with algorithmic ystemic lupus erythematosus (SLE)-likelihood assessment


name: Analysis of 8 IgG autoantibodies and 2 cell-bound complement activation products associated with systemic lupus erythematosus by enzyme-linked immunosorbent immunoassay (ELISA), flow cytometry and indirect immunofluorescence in serum specimen, individual components reported along with algorithmic ystemic lupus erythematosus (SLE)-likelihood assessment


name: Oncology (pancreas), DNA and mRNA next-generation sequencing analysis of 74 genes and analysis of CEA (CEACAM5) gene expression, pancreatic cyst fluid, algorithm reported as a categorical result (ie, negative, low probability of neoplasia or positive, high probability of neoplasia)


name: Oncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 35 genes (32 content and 3 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical result (ie, benign, intermediate, malignant)


name: mRNA gene expression profiling by real-time polymerase chain reaction (RT-PCR) of 35 genes (32 content and 3 housekeeping) associated with malignant melanoma in formalin-fixed paraffin-embedded (FFPE) tissue specimen, algorithm reported as categorical result (ie, benign, intermediate, malignant)


name: Oncology (cutaneous squamous cell carcinoma), mRNA gene expression profiling by RT-PCR of 40 genes (34 content and 6 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical risk result (ie, Class 1, Class 2A, Class 2B)


name: Borrelia burgdorferi (Lyme disease), OspA protein evaluation, urine


name: Oncology (lung cancer), four-probe FISH (3q29, 3p22.1, 10q22.3, 10cen) assay, whole blood, predictive algorithm-generated evaluation reported as decreased or increased risk for lung cancer


name: Pediatrics (congenital epigenetic disorders), whole genome methylation analysis by microarray for 50 or more genes, blood


name: Whole genome methylation analysis by microarray for 50 or more genes associated with congenital epigenetic disorders in blood specimen


name: Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using pretransplant peripheral blood, algorithm reported as a risk score for early acute rejection


name: Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using posttransplant peripheral blood, algorithm reported as a risk score for acute cellular rejection


name: Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 20 bacterial and fungal organisms and identification of 16 associated antibiotic-resistance genes, multiplex amplified probe technique


name: Identification of 20 bacterial and fungal genitourinary pathogens and identification of 16 associated antibiotic-resistance genes by multiplex amplified DNA probe technique


name: Neurology (autism spectrum disorder [ASD]), quantitative measurements of 14 acyl carnitines and microbiome-derived metabolites, liquid chromatography with tandem mass spectrometry (LC-MS/MS), plasma, results reported as negative or positive for risk of metabolic subtypes associated with ASD


name: Infectious agent detection by nucleic acid (DNA and RNA), central nervous system pathogen, metagenomic next-generation sequencing, cerebrospinal fluid (CSF), identification of pathogenic bacteria, viruses, parasites, or fungi


name: DNA and mRNA next-generation sequencing analysis in cerebrospinal fluid specimen for detection of organisms causing disease in central nervous system


name: Identification of central nervous system pathogenic bacteria by metagenomic next-generation DNA sequencing in cerebrospinal fluid (CSF) specimen


name: Identification of central nervous system pathogenic fungi by metagenomic next-generation DNA sequencing in cerebrospinal fluid (CSF) specimen


name: Identification of central nervous system pathogenic viruses by metagenomic next-generation DNA sequencing in cerebrospinal fluid (CSF) specimen


name: Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 83 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden


name: Targeted genomic sequence analysis of 83 or more genes in cell free circulating DNA for detection of abnormalities associated with solid organ cancers


name: Fetal aneuploidy (trisomy 13, 18, and 21), DNA sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy, includes sex reporting, if performed


name: DNA sequence analysis of selected regions for detection of abnormal fetal chromosome number (trisomy 13, 18, and 21) in maternal plasma specimen, algorithm reported as risk score for each trisomy, includes sex reporting, if performed


name: DNA sequence analysis of selected regions for fetal aneuploidy (trisomy 13, 18, and 21) in maternal plasma specimen, algorithm reported as risk score for each trisomy


name: Drug assay, definitive, 120 or more drugs and metabolites, urine, quantitative liquid chromatography with tandem mass spectrometry (LC-MS/MS), includes specimen validity and algorithmic analysis describing drug or metabolite and presence or absence of risks for a significant patient-adverse event, per date of service


name: Definitive drug testing for 120 or more drugs and metabolites in urine specimen


name: Oncology (neoplasia), exome and transcriptome sequence analysis for sequence variants, gene copy number amplifications and deletions, gene rearrangements, microsatellite instability and tumor mutational burden utilizing DNA and RNA from tumor with DNA from normal blood or saliva for subtraction, report of clinically significant mutation(s) with therapy associations


name: Exome and transcriptome sequence analysis of DNA and RNA from tumor with DNA from normal blood or saliva for subtraction, report of clinically significant mutations with therapy associations


name: Exome and transcriptome sequence analysis for sequence variants, gene copy number amplifications and deletions, gene rearrangements, microsatellite instability and tumor mutational burden in DNA and RNA from tumor specimen with DNA from normal blood specimen for subtraction, with report of clinically significant mutations with therapy associations


name: Exome and transcriptome sequence analysis for sequence variants, gene copy number amplifications and deletions, gene rearrangements, microsatellite instability and tumor mutational burden in DNA and RNA from tumor specimen with DNA from normal saliva specimen for subtraction, with report of clinically significant mutations with therapy associations


name: Infectious agent detection by nucleic acid (DNA or RNA), vaginal pathogen panel, identification of 27 organisms, amplified probe technique, vaginal swab


name: Vaginal pathogen panel for identification of 27 organisms by amplified DNA probe technique in vaginal swab specimen


name: Oncology (hematolymphoid neoplasia), optical genome mapping for copy number alterations and gene rearrangements utilizing DNA from blood or bone marrow, report of clinically significant alterations


name: Optical genome mapping of DNA from blood or bone marrow specimen, report of clinically significant alterations associated with blood or lymph system cancers


name: Optical genome mapping for copy number alterations and gene rearrangements associated with hematolymphoid neoplasia utilizing DNA from blood specimen, with report of clinically significant alterations


name: Optical genome mapping for copy number alterations and gene rearrangements associated with hematolymphoid neoplasia utilizing DNA from bone marrow specimen, with report of clinically significant alterations


name: Oncology (pan-tumor), genetic profiling of 8 DNA-regulatory (epigenetic) markers by quantitative polymerase chain reaction (qPCR), whole blood, reported as a high or low probability of responding to immune checkpoint-inhibitor therapy


name: Genetic profiling of 8 epigenetic markers to evaluate probability of responding to immune checkpoint-inhibitor therapy for cancer


name: Oncology (liver), surveillance for hepatocellular carcinoma (HCC) in high-risk patients, analysis of methylation patterns on circulating cell-free DNA (cfDNA) plus measurement of serum of AFP/AFP-L3 and oncoprotein des-gamma-carboxy-prothrombin (DCP), algorithm reported as normal or abnormal result


name: Survelliance for liver cancer in high risk patients using algorithm


name: Oncology (solid organ), targeted genomic sequence analysis, formalin-fixed paraffin-embedded (FFPE) tumor tissue, DNA analysis, 84 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden


name: Targeted genomic sequence analysis of 84 or more genes for detection of abnormalities associated with cancer of body organ


name: Rare diseases (constitutional/heritable disorders), whole genome sequence analysis, including small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions, fetal sample, identification and categorization of genetic variants


name: Rare diseases (constitutional/heritable disorders), whole genome sequence analysis, including small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions, blood or saliva, identification and categorization of genetic variants, each comparator genome (eg, parent)


name: Whole genome sequence analysis of comparator genome (parent) for detection of abnormalities associated with rare constitutional/heritable diseases


name: Whole genome sequence analysis for detection of small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions in blood specimen, with identification and categorization of genetic variants associated with rare constitutional and heritable disorders, each comparator genome


name: Whole genome sequence analysis for detection of small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions in blood specimen, with identification and categorization of genetic variants associated with rare constitutional and heritable disorders, each parent genome


name: Whole genome sequence analysis for detection of small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions in saliva specimen, with identification and categorization of genetic variants associated with rare constitutional and heritable disorders, each comparator genome


name: Whole genome sequence analysis for detection of small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions in saliva specimen, with identification and categorization of genetic variants associated with rare constitutional and heritable disorders, each parent genome


name: Oncology (plasma cell disorders and myeloma), circulating plasma cell immunologic selection, identification, morphological characterization, and enumeration of plasma cells based on differential CD138, CD38, CD19, and CD45 protein biomarker expression, peripheral blood


name: Evaluation of plasma cells for detection of abnormalities associated with plasma cell disorders and myeloma